Showing results (281-290 of 303) with videos related to
Sort By:
Pageof 31
Leukemia Research|March 10, 2015
Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutationsNing Li, Qiu-Mei Yao, Robert Peter Gale, et al.Frontiers in Genetics|December 17, 2020
A Variant in the Nicotinic Acetylcholine Receptor Alpha 3 Subunit Gene Is Associated With Hypertension Risks in Hypogonadic PatientsTao Wu, Yujia Wang, Wei Shi, et al.Oncogene|July 1, 2026
Matrix stiffness drives HCC invasion and metastasis via interfering with TRIM21-mediated SCD1 ubiquitinationYe Xu, Jia-Jun Li, Lian-Er Zhou, et al.BMC Cancer|March 18, 2022
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysisZe-Hong Huang, Gui-Yang Lu, Ling-Xian Qiu, et al.Scientific Reports|September 29, 2018
Analysis of the association of EPHB6, EFNB1 and EFNB3 variants with hypertension risks in males with hypogonadismTao Wu, Bi-Qi Zhang, John Raelson, et al.The Science of the Total Environment|March 3, 2022
Zinc alters behavioral phenotypes, neurotransmitter signatures, and immune homeostasis in male zebrafish (Danio rerio)Fan Yu, Zhi-Shuai Hou, Hong-Rui Luo, et al.Frontiers in Cardiovascular Medicine|December 26, 2022
Corrigendum: Artificial intelligence-assisted remote detection of ST-elevation myocardial infarction using a mini-12-lead electrocardiogram device in prehospital ambulance careKe-Wei Chen, Yu-Chen Wang, Meng-Hsuan Liu, et al.Bioengineered|August 11, 2020
Could cytokine release syndrome induce acute myelofibrosis in CD19 chimeric antigen receptor T cells therapy?Xun Lai, Yun Yan Sun, Lung Ji Chang, et al.World Journal of Gastroenterology|June 5, 2002
Epidemiological and histopathological study of relevance of Guizhou Maotai liquor and liver diseasesJun Wu, Ming-Liang Cheng, Guo-Hao Zhang, et al.Oncotarget|November 2, 2016
Carboplatin-induced hematotoxicity among patients with non-small cell lung cancer: Analysis on clinical adverse events and drug-gene interactionsYi-Ju Cheng, Ran Wu, Ming-Liang Cheng, et al.Pageof 31